237 related articles for article (PubMed ID: 15670668)
1. Mechanisms of non-alcoholic steatohepatitis.
McClain CJ; Mokshagundam SP; Barve SS; Song Z; Hill DB; Chen T; Deaciuc I
Alcohol; 2004 Aug; 34(1):67-79. PubMed ID: 15670668
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic steatohepatitis and metabolic syndrome.
Machado M; Cortez-Pinto H
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and therapy in NASH].
Tokushige K
Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic steatohepatitis.
Das K; Kar P
J Assoc Physicians India; 2005 Mar; 53():195-9. PubMed ID: 15926603
[TBL] [Abstract][Full Text] [Related]
5. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].
Spahr L; Rubbia-Brandt L; Hadengue A
Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004
[TBL] [Abstract][Full Text] [Related]
6. [Non-alcoholic steatohepatitis].
Duvnjak M; Virović L
Acta Med Croatica; 2003; 57(3):189-99. PubMed ID: 14582465
[TBL] [Abstract][Full Text] [Related]
7. [Pathogenic molecular mechanisms in non-alcoholic steatohepatitis].
Alvarez-Martínez HE; Montaño-Estrada LF; Hernández-Cruz P; Pérez-Campos E
Rev Gastroenterol Mex; 2004; 69(3):176-83. PubMed ID: 15759791
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic steatohepatitis: review of a growing medical problem.
Te Sligte K; Bourass I; Sels JP; Driessen A; Stockbrugger RW; Koek GH
Eur J Intern Med; 2004 Feb; 15(1):10-21. PubMed ID: 15066643
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S; Younossi ZM
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
[TBL] [Abstract][Full Text] [Related]
11. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
Federico A; Trappoliere M; Loguercio C
Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
[TBL] [Abstract][Full Text] [Related]
12. Review article: Drug therapy for non-alcoholic fatty liver disease.
Comar KM; Sterling RK
Aliment Pharmacol Ther; 2006 Jan; 23(2):207-15. PubMed ID: 16393299
[TBL] [Abstract][Full Text] [Related]
13. [Non alcoholic steatohepatitis: an emergent and potentially serious pathology].
Elloumi H; Arfaoui D; Joudène M; Sriha B; Korbi M; Ajmi S
Tunis Med; 2004 Jun; 82(6):484-91. PubMed ID: 15517946
[TBL] [Abstract][Full Text] [Related]
14. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
15. [Alcoholic and nonalcoholic steatohepatitis: the same disease! II. Management].
Spahr L; Hadengue A
Rev Med Suisse; 2005 Sep; 1(31):2032-4. PubMed ID: 16212005
[TBL] [Abstract][Full Text] [Related]
16. [Role of lipid peroxidation in non-alcoholic steatohepatitis].
Fraenkel E; Lazúrová I; Fehér J
Orv Hetil; 2004 Mar; 145(12):611-8. PubMed ID: 15119115
[TBL] [Abstract][Full Text] [Related]
17. Recent concepts in non-alcoholic fatty liver disease.
Adams LA; Angulo P
Diabet Med; 2005 Sep; 22(9):1129-33. PubMed ID: 16108837
[TBL] [Abstract][Full Text] [Related]
18. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Younossi ZM
Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
Petta S; Muratore C; Craxì A
Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
Tarantino G; Saldalamacchia G; Conca P; Arena A
J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
